共 70 条
- [1] Guidelines on prostate cancer, Arnhem, (2012)
- [2] Thomsen F.B., Brasso K., Klotz L.H., Roder M.A., Berg K.D., Iversen P., Active surveillance for clinically localized prostate cancer–a systematic review, J Surg Oncol, 109, pp. 830-835, (2014)
- [3] Heidenreich A., Bellmunt J., Bolla M., Et al., EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease, Eur Urol, 59, pp. 61-71, (2011)
- [4] Rothwax J.T., George A.K., Wood B.J., Pinto P.A., Multiparametric MRI in biopsy guidance for prostate cancer: fusion-guided, Biomed Res Int, 2014, (2014)
- [5] Eskew L.A., Bare R.L., McCullough D.L., Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate, J Urol, 157, pp. 199-202, (1997)
- [6] Presti J.C., O'Dowd G.J., Miller M.C., Mattu R., Veltri R.W., Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study, J Urol, 169, pp. 125-129, (2003)
- [7] Babaian R.J., Toi A., Kamoi K., Et al., A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy, J Urol, 163, pp. 152-157, (2000)
- [8] Noguchi M., Stamey T.A., McNeal J.E., Yemoto C.M., Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer, J Urol, 166, pp. 104-109, (2001)
- [9] Bott S.R., Young M.P., Kellett M.J., Parkinson M.C., Anterior prostate cancer: is it more difficult to diagnose?, BJU Int, 89, pp. 886-889, (2002)
- [10] Eberhardt S.C., Carter S., Casalino D.D., Et al., ACR appropriateness criteria prostate cancer–pretreatment detection, staging, and surveillance, J Am Coll Radiol, 10, pp. 83-92, (2013)